1. 1329PEfficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy. (23rd October 2018) Authors: Hernando Cubero, J; Grande, E; Jimenez Fonseca, P; Villabona, C; Trigo Perez, J M; Martinez Trufero, J; Pajares Bernad, I; Lopez, C; Alonso, T; Biarnes, J; Ramón, T; Cajal, Y; Duran, M; Grau, J J; Arevalo Lobera, S; Mesia Nin, R; Llanos, M; Dalmau Portulas, E; Alvarez, C; Zafon, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗